Literature DB >> 21440775

Management of early hepatic arterial thrombosis after pediatric living-donor liver transplantation.

S Sevmis1, H Karakayali, N U Tutar, F Boyvat, F Ozcay, A Torgay, M Haberal.   

Abstract

PURPOSE: Early hepatic arterial thrombosis after living-donor liver transplantation is a cause of graft loss and patient mortality. We analyzed early hepatic arterial thrombosis after pediatric living-donor liver transplantation.
MATERIALS AND METHODS: Since September 2001, we performed 122 living-donor liver transplants on 119 children. Ten hepatic arterial thromboses developed in the early postoperative period. The 7 male and 4 female patients of overall mean age of 6.3±6.1 years underwent 5 left lateral segment, 3 right lobe, and 2 left lobe transplantations.
RESULTS: Among 10 children with hepatic arterial thrombosis, 8 diagnoses were made before any elevation of liver function tests. One child displayed fever at the time of the hepatic arterial thrombosis. The median time for diagnosis was 5 days. Hepatic arterial thrombosis was treated with interventional radiologic techniques in 9 children, with 1 undergoing surgical exploration owing to failed radiologic approaches, and a reanastomosis using a polytetrafluoroethylene graft. Successful revascularization was achieved in all children, except 1. Four children died, the remaining 6 are alive with good graft function. During the mean follow-up of 52.7±18.8 months, multiple intrahepatic biliary stenoses were identified in 1 child.
CONCLUSION: Routine Doppler ultrasonography is effective for the early diagnosis of hepatic arterial thrombosis. Interventional radiologic approaches such as arterial thrombolysis and intraluminal stent placement should be the first therapeutic choices for patients with early hepatic arterial thrombosis; if radiologic methods fail, one must consider surgical exploration or retransplantation.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21440775     DOI: 10.1016/j.transproceed.2011.01.011

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  6 in total

1.  Risk factors of hepatic artery thrombosis in pediatric deceased donor liver transplantation.

Authors:  Nan Ma; Zhuolun Song; Chong Dong; Chao Sun; Xingchu Meng; Wei Zhang; Kai Wang; Bin Wu; Shanni Li; Hong Qin; Chao Han; Haohao Li; Wei Gao; Zhongyang Shen
Journal:  Pediatr Surg Int       Date:  2019-06-15       Impact factor: 1.827

2.  Minimally invasive endovascular and biliary treatments of children with acute hepatic artery thrombosis following liver transplantation.

Authors:  Roberto Miraglia; Luigi Maruzzelli; Settimo Caruso; Gianluca Marrone; Kelvin Cortis; Marco Spada; Angelo Luca
Journal:  Pediatr Radiol       Date:  2014-01

3.  Post-operative heparin reduces early venous thrombotic complications after orthotopic paediatric liver transplantation.

Authors:  Giovanna Colombo; Cinzia Giaccherini; Alberto Benzi; Floriana Ferrari; Daniele Bonacina; Manuela Corno; Michele Colledan; Maria Grazia Alessio; Ezio Bonanomi; Mirco Nacoti; Anna Falanga
Journal:  Blood Transfus       Date:  2021-03-12       Impact factor: 3.443

4.  Vascular complications in biliary atresia patients undergoing living donor liver transplantation: Analysis of 110 patients over 10 years.

Authors:  Bhavin Vasavada; Chao Long Chen
Journal:  J Indian Assoc Pediatr Surg       Date:  2015 Jul-Sep

5.  RISK FACTORS ASSOCIATED WITH HEPATIC ARTERY THROMBOSIS: ANALYSIS OF 1050 LIVER TRANSPLANTS.

Authors:  Luis Eduardo Veras Pinto; Gustavo Rego Coelho; Madalena Maria Silva Coutinho; Orlando Jorge Martins Torres; Plinio Cunha Leal; Ciro Bezerra Vieira; José Huygens Parente Garcia
Journal:  Arq Bras Cir Dig       Date:  2021-01-25

6.  Hepatic arterial and portal venous complications after adult and pediatric living donor liver transplantation, risk factors, management and outcome (A retrospective cohort study).

Authors:  Emad Hamdy Gad; Mohammed Alsayed Abdelsamee; Yasmin Kamel
Journal:  Ann Med Surg (Lond)       Date:  2016-04-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.